Zepp Health Price to Book Ratio 2017-2025 | ZEPP
Historical price to book ratio values for Zepp Health (ZEPP) over the last 10 years. The current price to book ratio for Zepp Health as of January 16, 2026 is 1.44.
| Zepp Health Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-01-16 | 23.02 | 0.00 | |
| 2025-09-30 | 45.78 | 0.00 | |
| 2025-06-30 | 2.66 | 0.00 | |
| 2025-03-31 | 2.96 | $16.11 | 0.18 |
| 2024-12-31 | 2.60 | 0.00 | |
| 2024-09-30 | 4.35 | $21.58 | 0.20 |
| 2024-06-30 | 2.40 | $21.85 | 0.11 |
| 2024-03-31 | 4.08 | 0.00 | |
| 2023-12-31 | 5.68 | $23.44 | 0.24 |
| 2023-09-30 | 4.60 | 0.00 | |
| 2023-06-30 | 4.56 | 0.00 | |
| 2023-03-31 | 5.24 | 0.00 | |
| 2022-12-31 | 5.80 | $25.39 | 0.23 |
| 2022-09-30 | 5.48 | 0.00 | |
| 2022-06-30 | 7.40 | 0.00 | |
| 2022-03-31 | 11.52 | 0.00 | |
| 2021-09-30 | 31.07 | 0.00 | |
| 2021-03-31 | 41.67 | 0.00 | |
| 2020-12-31 | 45.85 | $26.76 | 1.71 |
| 2020-09-30 | 49.71 | 0.00 | |
| 2020-06-30 | 47.82 | 0.00 | |
| 2020-03-31 | 50.76 | 0.00 | |
| 2019-12-31 | 46.50 | $23.19 | 2.01 |
| 2019-09-30 | 38.69 | 0.00 | |
| 2019-06-30 | 38.69 | 0.00 | |
| 2019-03-31 | 50.64 | 0.00 | |
| 2018-12-31 | 38.03 | $17.42 | 2.18 |
| 2018-09-30 | 41.40 | 0.00 | |
| 2018-06-30 | 38.11 | 0.00 | |
| 2018-03-31 | 41.13 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.326B | $0.183B |
| Zepp Health Corp. developed a platform of proprietary technology including AI chips, biometric sensors and health data algorithms, which drive a broadening line of smart health products for consumers and analytics services for insurers, healthcare providers, employers, drug and treatment companies. Zepp Health Corp., formerly known as Huami Corporation, is based in CUPERTINO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.991B | 41.62 |
| Tempus AI (TEM) | United States | $12.261B | 0.00 |
| Doximity (DOCS) | United States | $7.729B | 31.82 |
| Hims & Hers Health (HIMS) | United States | $7.109B | 57.83 |
| IRHYTHM HLDGS (IRTC) | United States | $5.543B | 0.00 |
| Hinge Health (HNGE) | United States | $3.445B | 0.00 |
| Heartflow (HTFL) | United States | $3.076B | 0.00 |
| Privia Health (PRVA) | United States | $2.935B | 183.54 |
| Inspire Medical Systems (INSP) | United States | $2.803B | 46.38 |
| 10x Genomics (TXG) | United States | $2.683B | 0.00 |
| Omnicell (OMCL) | United States | $2.288B | 46.77 |
| Azenta (AZTA) | United States | $1.835B | 75.30 |
| Enovis (ENOV) | United States | $1.387B | 7.29 |
| Clover Health Investments (CLOV) | United States | $1.354B | 0.00 |
| Schrodinger (SDGR) | United States | $1.287B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.149B | 0.00 |
| Phreesia (PHR) | United States | $0.992B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.886B | 0.00 |
| Talkspace (TALK) | United States | $0.634B | 127.67 |
| Standard BioTools (LAB) | United States | $0.608B | 0.00 |
| Claritev (CTEV) | United States | $0.497B | 0.00 |
| Evolent Health (EVH) | United States | $0.440B | 0.00 |
| Carlsmed (CARL) | United States | $0.360B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.349B | 0.00 |
| TruBridge (TBRG) | United States | $0.326B | 14.99 |
| Senseonics Holdings (SENS) | United States | $0.297B | 0.00 |
| CapsoVision (CV) | United States | $0.283B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.263B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.190B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.175B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.175B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.166B | 0.00 |
| CareCloud (CCLD) | United States | $0.121B | 6.63 |
| Outset Medical (OM) | United States | $0.095B | 0.00 |
| American Well (AMWL) | United States | $0.078B | 0.00 |
| HeartBeam (BEAT) | United States | $0.076B | 0.00 |
| Pulmonx (LUNG) | United States | $0.075B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.069B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.061B | 0.00 |
| 111 (YI) | China | $0.049B | 0.00 |
| Precipio (PRPO) | United States | $0.042B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.040B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.024B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.009B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |